BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2578606)

  • 1. Cytotoxicity and the inhibition of ribosomal RNA processing in human colon carcinoma cells.
    Cohen MB; Glazer RI
    Mol Pharmacol; 1985 Feb; 27(2):308-13. PubMed ID: 2578606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the cellular and RNA-dependent effects of sangivamycin and toyocamycin in human colon carcinoma cells.
    Cohen MB; Glazer RI
    Mol Pharmacol; 1985 Mar; 27(3):349-55. PubMed ID: 2579317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of cell lethality with incorporation of 5-fluorouracil and 5-fluorouridine into nuclear RNA in human colon carcinoma cells in culture.
    Glazer RI; Lloyd LS
    Mol Pharmacol; 1982 Mar; 21(2):468-73. PubMed ID: 7099147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 9-Deazaadenosine. Cytocidal activity and effects on nucleic acids and protein synthesis in human colon carcinoma cells in culture.
    Glazer RI; Hartman KD; Knode MC
    Mol Pharmacol; 1983 Sep; 24(2):309-15. PubMed ID: 6888372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, cytotoxicity, and antiviral activity of some acyclic analogues of the pyrrolo[2,3-d]pyrimidine nucleoside antibiotics tubercidin, toyocamycin, and sangivamycin.
    Gupta PK; Daunert S; Nassiri MR; Wotring LL; Drach JC; Townsend LB
    J Med Chem; 1989 Feb; 32(2):402-8. PubMed ID: 2913300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of non-nucleoside analogs of toyocamycin, sangivamycin, and ++thiosangivamycin: influence of various 7-substituents on antiviral activity.
    Renau TE; Wotring LL; Drach JC; Townsend LB
    J Med Chem; 1996 Feb; 39(4):873-80. PubMed ID: 8632411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and biochemical studies on mutants of CHO cells resistant to 7-deazapurine nucleosides: differences in the mechanisms of action of toyocamycin and tubercidin.
    Gupta RS; Mehta KD
    Biochem Biophys Res Commun; 1984 Apr; 120(1):88-95. PubMed ID: 6712702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleic acid related compounds. 51. Synthesis and biological properties of sugar-modified analogues of the nucleoside antibiotics tubercidin, toyocamycin, sangivamycin, and formycin.
    De Clercq E; Balzarini J; Madej D; Hansske F; Robins MJ
    J Med Chem; 1987 Mar; 30(3):481-6. PubMed ID: 3820218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokinetic and biochemical effects of 5-iminodaunorubicin in human colon carcinoma in culture.
    Glazer RI; Hartman KD; Richardson CL
    Cancer Res; 1982 Jan; 42(1):117-21. PubMed ID: 7053840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro translational activity of messenger RNA following treatment of human colon carcinoma cells with sangivamycin.
    Glazer RI; Hartman KD
    Mol Pharmacol; 1983 Nov; 24(3):509-12. PubMed ID: 6633511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1-beta-D-arabinosyl-5-azacytosine. Cytocidal activity and effects on the synthesis and methylation of DNA in human colon carcinoma cells.
    Glazer RI; Knode MC
    Mol Pharmacol; 1984 Sep; 26(2):381-7. PubMed ID: 6207423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of purine and 7-deazapurine nucleoside analogues of 6-N-(4-Nitrobenzyl)adenosine; inhibition of nucleoside transport and proliferation of cancer cells.
    Rayala R; Theard P; Ortiz H; Yao S; Young JD; Balzarini J; Robins MJ; Wnuk SF
    ChemMedChem; 2014 Sep; 9(9):2186-92. PubMed ID: 24788480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral activity of C-5 substituted tubercidin analogues.
    Bergstrom DE; Brattesani AJ; Ogawa MK; Reddy PA; Schweickert MJ; Balzarini J; De Clercq E
    J Med Chem; 1984 Mar; 27(3):285-92. PubMed ID: 6699874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and functional relationships of toyocamycin on NPM-translocation.
    Finch RA; Revankar GR; Chan PK
    Anticancer Drug Des; 1997 Apr; 12(3):205-15. PubMed ID: 9154111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro translation of messenger RNA following exposure of human colon carcinoma cells in culture to 5-fluorouracil and 5-fluorouridine.
    Glazer RI; Hartman KD
    Mol Pharmacol; 1983 Mar; 23(2):540-6. PubMed ID: 6835205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of a selective inhibitor of ribosomal RNA on induction of differentiation of the Friend cell].
    Madaule P; Hamelin R; Tavitian A
    C R Seances Acad Sci III; 1982 Apr; 294(15):735-8. PubMed ID: 6812875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of rRNA synthesis and processing in animal cells. Effect of nucleoside analogues.
    Iapalucci-Espinoza S; Franze-Fernandez MT
    Biochem J; 1982 Feb; 202(2):325-32. PubMed ID: 6212050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonistic effect of polyinosinic-polycytidylic acid on the cell lethality produced by 5-fluorouracil in human colon carcinoma cells in vitro.
    Iigo M; Glazer RI
    Cancer Res; 1985 May; 45(5):1953-7. PubMed ID: 2580613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of action of a new antitumor ribonucleoside, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd, TAS-106), differs from that of 5-fluorouracil.
    Kazuno H; Shimamoto Y; Tsujimoto H; Fukushima M; Matsuda A; Sasaki T
    Oncol Rep; 2007 Jun; 17(6):1453-60. PubMed ID: 17487404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic effects of sangivamycin in sarcoma 180 in vitro.
    Ritch PS; Glazer RI; Cunningham RE; Shackney SE
    Cancer Res; 1981 May; 41(5):1784-8. PubMed ID: 7214345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.